The lncRNA A2M-AS1, a promoter of ferroptosis, is expressed at low levels in PDAC, and its downregulation is correlated with poor prognosis [143]
This is where it gets genuinely interesting
This multi-symptom, multi-system involvement, and the fact that mast cell activation syndrome is not well-recognized create an extreme challenge for physicians to diagnose
Would recommend and will likely go back when a clinic is needed
"The GLP-1 has been a lifesaver
Use in type 1 diabetes The ADJUNCT ONE trial (Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes), 55 the ADJUNCT TWO trial, 56 and a large meta-analysis 57 found reductions in hemoglobin A1c, body weight, and total daily dose of insulin, but also highlighted an increase in hyperglycemia with ketosis in patients with type 1 diabetes mellitus receiving liraglutide or exenatide in combination with insulin